日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies.

CD47阻断驱动的坏死性凋亡可与BCL-2抑制驱动的淋巴恶性肿瘤细胞凋亡相辅相成。

Chong Stephen J F, Valentin Rebecca, Wang Jing, Zhu Fen, Gokhale Prafulla C, Eschle Benjamin K, Garbicz Filip, Iskandar Kartini, Sewastianik Tomasz, Toh Brienne C Y, Penailillo Johany, Peluso Marisa O, Zhang Jeremy, Hackett Liam, Collins Mary C, Lehmberg Timothy Z, Adam Ammar, Zhang Li, Armet Caroline M, Rausch Matthew, Lee Benjamin H, Holland Pamela M, Palombella Vito J, Paterson Alison M, Kong Li Ren, Ten Hacken Elisa, Guerriero Jennifer L, Herbaux Charles, Wu Catherine J, Chng Wee Joo, Pervaiz Shazib, Niemann Carsten U, Carrasco Ruben D, Davids Matthew S

Synergistic fusion of CD47, VE-cadherin and mussel adhesion protein promotes endothelialization and suppresses inflammation in vascular stents.

CD47、VE-钙黏蛋白和贻贝黏附蛋白的协同融合可促进血管支架内皮化并抑制炎症。

Yan Wenhua, Li Shuyu, Zhang Tian, Huang Junli, Deng Chengchen, Yuan Kunshan, Huang Nan, Zhang Haijun, Wang Guixue

Dichotomous role of CD47-SIRPα axis: Leveraging opposing functions in phagocytic resistance and transport assistance for enhanced nanocarrier biocompatibility and tumor penetration.

CD47-SIRPα轴的双重作用:利用其在吞噬抵抗和运输辅助方面的相反功能,增强纳米载体的生物相容性和肿瘤渗透性。

Duan Xuehui, Tang Yixuan, Tang Zhongjie, Du Yan, Chu Xinlei, Liu XinLong, Liu Zhanyan, Zhao Kun, Xu Wei, Li Chong

Core Fucosylation Represses SMURF1-Dependent Degradation of CD47 to Promote Tumor Immune Evasion

核心岩藻糖基化抑制SMURF1依赖的CD47降解,从而促进肿瘤免疫逃逸

Cao, Yuting; Chai, Siyuan; Li, Mingyang; Chen, Xiaoming; Hu, Jiating; Lin, Bingyi; Wu, Liming; Yi, Wen; Zhu, Qiang

Ir(III) Complexes Convert Cold to Hot Tumors via Ferroptosis/Necroptosis-Driven Immunogenic Cell Death and Photosensitized CD47 Downregulation.

Ir(III)配合物通过铁死亡/坏死性细胞死亡驱动的免疫原性细胞死亡和光敏CD47下调将冷肿瘤转化为热肿瘤。

Yu Long-Bo, Wang Peng, Shen Qing-Hua, Guan Qi-Xin, Li Zhi-Yuan, Han Ying-Ying, Zhang Xin-Yi, Hu Qing-Yuan, Tan Cai-Ping

Cancer Immunotherapy via Disruption of Integrin αvβ3 and CD47 Costabilization on Cancer Cell Surface.

通过破坏癌细胞表面的整合素αvβ3和CD47共稳定作用进行癌症免疫治疗。

Engineering macrophages for effective and safe targeting of CD47 cancer cells in the tumor microenvironment

改造巨噬细胞以实现对肿瘤微环境中CD47癌细胞的有效且安全的靶向治疗

Andón, Fernando Torres; Rosales Sánchez, Ailenis; Pensado-López, Alba; García-Campelo, Rosario; Takimoto, Chris H

CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy.

通过操纵 SPOP-USP2 轴使 CD47 不稳定,可增强巨噬细胞的吞噬作用和癌症免疫疗法。

Yan Peiqiang, Bu Xia, Hou Tao, Chen Li, Zhong Guoxuan, Huang Daoyuan, Wang Jingchao, Qi Yihang, Jiang Weiwei, Li Zhe, Xue Xutong, Gao Yang, Liu Jing, Inuzuka Hiroyuki, Freeman Gordon J, Wei Wenyi, Dai Xiaoming

Dual PD-1/IL-2Rα targeting restores CD8(+) T cell fitness via STAT5/CD47 axis in SMARCA4-deficient NSCLC.

双重 PD-1/IL-2Rα 靶向治疗通过 STAT5/CD47 轴恢复 SMARCA4 缺陷型 NSCLC 中的 CD8(+) T 细胞功能。

Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma

靶向缺氧外泌体IGFBP2可克服胶质母细胞瘤中CD47介导的免疫逃逸

Qi, Yanhua; Zhao, Rongrong; Zhang, Xinglong; Xia, Huize; Zhang, Ping; Wang, Qingtong; Zhao, Shulin; Wang, Shaobo; Zhao, Hongyu; Guo, Xiaofan; Qiu, Wei; Li, Boyan; Pan, Ziwen; Qiu, Jiawei; Gao, Zijie; Wang, Chengwei; Lu, Haiquan; Li, Gang; Xue, Hao